{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:39Z","timestamp":1791925419230,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.vaccine.2009.06.095","type":"journal-article","created":{"date-parts":[[2009,7,18]],"date-time":"2009-07-18T09:18:07Z","timestamp":1247908687000},"page":"5320-5325","source":"Crossref","is-referenced-by-count":33,"title":["Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains"],"prefix":"10.1016","volume":"27","author":[{"given":"Claudius","family":"Malerczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Selhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebl","family":"Tordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.06.095_bib1","first-page":"207","article-title":"Bat lyssaviruses in Europe","volume":"187","author":"Schneider","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.095_bib2","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","article-title":"Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity","volume":"75","author":"Badrane","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.06.095_bib3","series-title":"Virus taxonomy, VIIIth report of the ICTV","first-page":"623","article-title":"Rhabdoviridae","author":"Tordo","year":"2004"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.095_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.5694\/j.1326-5377.2000.tb124126.x","article-title":"Australian bat lyssavirus infection: a second human case, with a long incubation period","volume":"172","author":"Hanna","year":"2000","journal-title":"Med J Aust"},{"issue":"24","key":"10.1016\/j.vaccine.2009.06.095_bib5","first-page":"504","article-title":"A human case of encephalitis due to a lyssavirus, recently identified in fruit bats","volume":"20","author":"Allworth","year":"1996","journal-title":"Communicable Diseases Intelligence (Commun Dis Intell)"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.095_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-1702(98)00025-2","article-title":"Characterisation of a novel lyssavirus isolated from pteropid bats in Australia","volume":"54","author":"Gould","year":"1998","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.095_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.virusres.2005.03.008","article-title":"Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition","volume":"111","author":"Kuzmin","year":"2005","journal-title":"Virus Res"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.095_bib8","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3201\/eid1212.060514","article-title":"Isolation of Lagos Bat Virus from water mongoose","volume":"12","author":"Markotter","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.06.095_bib9","series-title":"12th international meeting on advances in rabies research and control in the Americas","first-page":"46","article-title":"Bat rabies: spillover infection and reservoir establishment","author":"Smith","year":"2001"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.095_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3201\/eid1502.080637","article-title":"European bat lyssavirus transmission among cats, Europe","volume":"15","author":"Dacheux","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2009.06.095_bib11","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1128\/JVI.75.17.8096-8104.2001","article-title":"Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders","volume":"75","author":"Badrane","year":"2001","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.095_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1017\/S0950268803001481","article-title":"European bat lyssaviruses: an emerging zoonosis","volume":"131","author":"Fooks","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2009.06.095_bib13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/brain\/111.6.1505","article-title":"Fatal encephalitis caused by a bat-borne rabies-related virus. Clinical findings","volume":"111","author":"Roine","year":"1988","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.095_bib14","first-page":"542","article-title":"Rabies-related Yuli virus; identification with a panel of monoclonal antibodies","volume":"33","author":"Selimov","year":"1989","journal-title":"Acta Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.095_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jmv.10481","article-title":"Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis","volume":"71","author":"Fooks","year":"2003","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.095_bib16","first-page":"5","article-title":"Human rabies case caused from a bat bite in Ukraine","volume":"29","author":"Botvinkin","year":"2005","journal-title":"Rabies Bulletin Europe"},{"issue":"16","key":"10.1016\/j.vaccine.2009.06.095_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/vr.159.16.534-a","article-title":"Isolation of EBLV-2 in a Daubenton's bat (Myotis daubentonii) found in Oxfordshire","volume":"159","author":"Fooks","year":"2006","journal-title":"Vet Rec"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.06.095_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vetmic.2008.02.028","article-title":"First isolation of EBLV-2 in Germany","volume":"131","author":"Freuling","year":"2008","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.06.095_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00705-006-0853-5","article-title":"Epidemiology of bat rabies in Germany","volume":"152","author":"M\u00fcller","year":"2007","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2009.06.095_bib20","unstructured":"Rabies Bulletin Europe; available at: http:\/\/www.who-rabies-bulletin.org; assessed 01\/February\/2008."},{"key":"10.1016\/j.vaccine.2009.06.095_bib21","first-page":"195","article-title":"Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European bat lyssavirus type 1 and 2","author":"M\u00fcller","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.06.095_bib22","first-page":"439","article-title":"Reactogenicity and immunogenicity of the newly developed purified chick embryo cell (PCEC)-rabies vaccine in man","volume":"265","author":"Scheiermann","year":"1987","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg [A]"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.095_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0264-410X(86)90138-6","article-title":"An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule","volume":"4","author":"Vodopija","year":"1986","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.095_bib24","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.095_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0264-410X(87)90102-2","article-title":"Pre-exposure studies with purified chick embryo cell culture rabies vaccine and human diploid cell vaccine: serological and clinical responses in man","volume":"5","author":"Nicholson","year":"1987","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.095_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jpeds.2007.02.044","article-title":"Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe","volume":"151","author":"Kamoltham","year":"2007","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.095_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1708-8305.2006.00097.x","article-title":"Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine","volume":"14","author":"Malerczyk","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2009.06.095_bib28","series-title":"Improvements in rabies post-exposure treatment","first-page":"181","article-title":"Efficacy of PCEC vaccine in post-exposure rabies prophylaxis","author":"Ljubicic","year":"1985"},{"issue":"14","key":"10.1016\/j.vaccine.2009.06.095_bib29","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2009.06.095_bib30","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0264-410X(98)00064-4","article-title":"Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV)","volume":"16","author":"Dietzschold","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.095_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","article-title":"Efficacy of rabies biologics against new lyssaviruses from Eurasia","volume":"111","author":"Hanlon","year":"2005","journal-title":"Virus Res"},{"issue":"8505","key":"10.1016\/j.vaccine.2009.06.095_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(86)90384-3","article-title":"Human rabies vaccines induce neutralising antibodies against the European bat rabies virus (Duvenhage)","volume":"2","author":"Lafon","year":"1986","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.095_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0264-410X(88)90184-3","article-title":"Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice","volume":"6","author":"Lafon","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.095_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.06.095_bib35","first-page":"185","article-title":"Ability of rabies vaccine strains to elicit cross-neutralising antibodies","volume":"125","author":"Brookes","year":"2006","journal-title":"Dev Biol (Basel)"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.095_bib36","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"issue":"32","key":"10.1016\/j.vaccine.2009.06.095_bib37","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses","volume":"23","author":"Brookes","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.095_bib38","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","article-title":"Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison","volume":"89","author":"Wright","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.06.095_bib39","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody","author":"Smith","year":"1996"},{"issue":"1\u20133","key":"10.1016\/j.vaccine.2009.06.095_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vetmic.2007.03.024","article-title":"Susceptibility of domestic dogs and cats to Australian bat lyssavirus (ABLV)","volume":"123","author":"McColl","year":"2007","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2009.06.095_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0264-410X(97)00204-1","article-title":"DNA-based immunisation for exploring the enlargement of immunological cross-reactivity against the lyssaviruses","volume":"16","author":"Bahloul","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.095_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/viro.1993.1235","article-title":"Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine","volume":"194","author":"Tordo","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.06.095_bib43","first-page":"1","article-title":"Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes","author":"Weyer","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"28\u201329","key":"10.1016\/j.vaccine.2009.06.095_bib44","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","article-title":"Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis","volume":"19","author":"Hanlon","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.095_bib45","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies","volume":"84","author":"Schumacher","year":"1989","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.095_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0264-410X(91)90131-O","article-title":"Effective postexposure treatment of rabies-infected sheep with rabies immune globulin and vaccine","volume":"9","author":"Blancou","year":"1991","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.095_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/hv.3.5.4216","article-title":"Rabies antibody levels in bat handlers in the United Kingdom: immune response before and after purified chick embryo cell rabies booster vaccination","volume":"3","author":"Morris","year":"2007","journal-title":"Hum Vaccin"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09009773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09009773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T20:07:05Z","timestamp":1590005225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09009773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":47,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0264410X09009773"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}